Cormorant Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Cormorant Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-245,000	Closed	-$8.6M	–	49
2024 Q2	$8.6M	Sell	245,000 -205,000	-46%	-$8.12M	0.5%	38
2024 Q1	$19.7M	Hold	450,000	–	–	0.87%	33
2023 Q4	$16M	Sell	450,000 -150,000	-25%	-$4.48M	0.76%	31
2023 Q3	$16.2M	Hold	600,000	–	–	0.94%	28
2023 Q2	$14.1M	Buy	600,000 +250,000	+71%	+$5.14M	0.79%	32
2023 Q1	$4.81M	Hold	350,000	–	–	0.32%	49
2022 Q4	$6.36M	Sell	350,000 -68,320	-16%	-$1.15M	0.43%	50
2022 Q3	$6.24M	Buy	+418,320	New	+$5.43M	0.44%	50

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Cormorant Asset Management's IDYA Position: Q3 2024 in Review

Cormorant Asset Management sold out of IDEAYA Biosciences (IDYA) in Q3 2024, closing a stake of 245,000 shares — an estimated $8.6M sold.

Cormorant Asset Management first reported a position in IDYA in Q3 2022 and held it in 8 quarters. The position peaked at $19.7M in Q1 2024. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

Cormorant Asset Management reported no remaining IDEAYA Biosciences position as of Q3 2024 after selling out during the quarter.
Cormorant Asset Management sold 245,000 IDEAYA Biosciences shares in Q3 2024, an estimated $8.6M.
Cormorant Asset Management first reported a position in IDEAYA Biosciences in Q3 2022 and held it in 8 quarters.
Cormorant Asset Management's IDEAYA Biosciences position peaked at $19.7M in Q1 2024.
209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on Cormorant Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.